middle.news
BLS Pharmaceuticals Hits Record $75m Revenue, Locks $50m German Supply Deal
8:52am on Monday 27th of July, 2026 AEST
•
Pharmaceuticals
Read Story
BLS Pharmaceuticals Hits Record $75m Revenue, Locks $50m German Supply Deal
8:52am on Monday 27th of July, 2026 AEST
Key Points
FY26 revenue surged 156% to $74.98 million
Adjusted EBITDA soared 190% to $19 million
Secured $50 million pharmaceutical supply deal with ADREXpharma Germany
Expanded into Costa Rica's medicinal cannabis market
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Bls Pharmaceuticals (ASX:BLS)
OPEN ARTICLE